Back to Results

Remedent Inc (REMI)

Remedent Inc. is a healthcare company focused on oral care and cosmetic dentistry products in the United States and international markets. The company develops, manufactures, and distributes professional and over-the-counter offerings, including veneers and teeth-whitening products. Its portfolio includes River8 prefab veneers for minor tooth reshaping, GlamSmile ultra-thin veneers, and SmileMe Mirror, a tool designed to support quick smile consultations in dental practices. Remedent also provides SmileSketch simulation software, Treatment Pages used to explain selected procedures, and Condor, an intra-oral 3D scanner. In addition, the company offers dental implant solutions and related treatment concepts. Remedent was incorporated in 1986 and is headquartered in Gent, Belgium. Its common stock is traded on OTC Markets under the symbol REMI.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-REMI
—
—
—
—
—
—
Weak
—
—
—
0.0%
—
—
—
—
13.491 K
—
—
—
—
—
—
Valuation • Fair Value

Remedent Inc (OTC-REMI) Fair Value by Valuation Model

Compare the primary fair value estimate for Remedent Inc (OTC-REMI) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

Not available

Data is currently unavailable.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

NM

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Remedent Inc (OTC-REMI) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Remedent Inc (OTC-REMI)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

Not available

Data is currently unavailable.

Revenue Forecast

Not available

Data is currently unavailable.

EBITDA

0 K

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Remedent Inc (OTC-REMI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Remedent Inc (OTC-REMI)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

Not available

Data is currently unavailable.

Beneish M-Score

Not available

Data is currently unavailable.

Altman Z-Score

Not available

Data is currently unavailable.

FCF / Net Income

Not available

Data is currently unavailable.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Remedent Inc (OTC-REMI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Remedent Inc (OTC-REMI)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

Not available

Days to Earnings

Not available

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Remedent Inc (OTC-REMI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Remedent Inc (OTC-REMI) Stock Forecast & Technical Outlook

Review Remedent Inc (OTC-REMI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Not available

The 15-minute technical signal for Remedent Inc (OTC-REMI) is not currently available.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Not available

The 1-hour technical signal for Remedent Inc (OTC-REMI) is not currently available.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Remedent Inc (OTC-REMI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Remedent Inc (OTC-REMI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Remedent Inc (OTC-REMI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Remedent Inc (OTC-REMI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Remedent Inc (OTC-REMI) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

Remedent Inc (OTC-REMI) Stock FAQ

Quick answers about Remedent Inc (OTC-REMI) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
Not available
Data is currently unavailable
Valuation Rating
Not available
Classification is not available
Analyst Target
Not available
Data is currently unavailable
Financial Health
Weak
Current financial-health read

A fair value estimate for Remedent Inc (OTC-REMI) is not currently available in the latest data file.

A clear undervalued or overvalued classification is not currently available in the latest data file.

An analyst price target for Remedent Inc (OTC-REMI) is not currently available in the latest data file.

The current financial health read for Remedent Inc (OTC-REMI) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

Based on the current data, dividend yield is 0.0%.

The current market capitalization listed for Remedent Inc is 13.491 K.

The ticker symbol for Remedent Inc is OTC-REMI, and the stock is listed on OTC Markets.

Remedent Inc (OTC-REMI) is listed on OTC Markets.

Similar Healthcare Equipment & Supplies Stocks on OTC Markets View more

Essilor International SA (ESLOY) Essilor International SA (ESLOY)
Hoya Corp (HOCPY) Hoya Corp (HOCPY)
Siemens Healthineers AG ADR (SMMNY) Siemens Healthineers AG ADR (SMMNY)
Resmed Inc DRC (RSMDF) Resmed Inc DRC (RSMDF)
Terumo Corp ADR (TRUMY) Terumo Corp ADR (TRUMY)
Straumann Holding AG ADR (SAUHY) Straumann Holding AG ADR (SAUHY)
Sonova Holding AG (SONVY) Sonova Holding AG (SONVY)
Coloplast A (CLPBY) Coloplast A (CLPBY)
Fisher & Paykel Healthcare Ltd (FSPKF) Fisher & Paykel Healthcare Ltd (FSPKF)
Olympus Corp (OLYMY) Olympus Corp (OLYMY)
Demant A/S ADR (WILYY) Demant A/S ADR (WILYY)
Getinge Industrier AB (GNGBY) Getinge Industrier AB (GNGBY)
Sysmex Corp (SSMXY) Sysmex Corp (SSMXY)
ConvaTec Group plc ADR (CNVVY) ConvaTec Group plc ADR (CNVVY)
CochLear Ltd ADR (CHEOY) CochLear Ltd ADR (CHEOY)
Ansell Ltd ADR (ANSLY) Ansell Ltd ADR (ANSLY)
Carl Zeiss Meditec AG ADR (CZMWY) Carl Zeiss Meditec AG ADR (CZMWY)
Shandong Weigao Group Medical Polymer Co Ltd ADR (SHWGY) Shandong Weigao Group Medical Polymer Co Ltd ADR (SHWGY)
Elekta AB ADR (EKTAY) Elekta AB ADR (EKTAY)
Nihon Kohden Corp ADR (NHNKY) Nihon Kohden Corp ADR (NHNKY)
Top Glove Corporation Bhd ADR (TGLVY) Top Glove Corporation Bhd ADR (TGLVY)
Cyberdyne Inc ADR (CYBQY) Cyberdyne Inc ADR (CYBQY)
Paxman AB (PXMBF) Paxman AB (PXMBF)
Zomedica Corp (ZOMDF) Zomedica Corp (ZOMDF)